Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

(1) Background: Markers identifying which patients with metastatic, castration-resistant prostate cancer (mCRPC) will benefit from cabazitaxel therapy are currently lacking. Therefore, the aim of this study was to identify markers associated with outcome to cabazitaxel therapy based on counts and ge...

Full description

Bibliographic Details
Main Authors: Ingeborg E. de Kruijff, Anieta M. Sieuwerts, Wendy Onstenk, Jaco Kraan, Marcel Smid, Mai N. Van, Michelle van der Vlugt-Daane, Esther Oomen-de Hoop, Ron H.J. Mathijssen, Martijn P. Lolkema, Ronald de Wit, Paul Hamberg, Hielke J. Meulenbeld, Aart Beeker, Geert-Jan Creemers, John W.M. Martens, Stefan Sleijfer
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
mCRPC
prostate cancer
circulating tumor cells
CTCs
biomarker
Online Access:https://www.mdpi.com/2072-6694/11/8/1212

Internet

https://www.mdpi.com/2072-6694/11/8/1212

Similar Items